“If you have long-term (chronic) liver disease, you may have regular tests to check the ... You might be more likely to get ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Liver cancer is responsible for thousands of deaths each year - but one of the early symptoms is often ignored or mistaken ...

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led ...

Viking Therapeutics (VKTX) announced that final results from the company’s Phase 2b clinical trial of VK2809, the company’s novel ...

There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...

Chemomab Therapeutics (CMMB) announced that data from its Phase 2 SPRING trial in patients with primary sclerosing cholangitis was presented at ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint ... yet to share the data behind the ...

AI can help doctors diagnose early cases of fatty liver disease, a new study says.An AI program trained to spot a lead ...

1Division of Digestive and Liver Diseases, Department of Medicine, Irving Cancer Research Center Columbia University Medical Center, New York, New York. 2Columbia University Digestive and Liver ...

to secondary care, and back to managing a chronic disease, is a crucial aspect. The role of self-monitoring and artificial intelligence tools to support clinical decision making in managing liver ...

Nov 1 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Friday its weight-loss drug met the main goal of a late-stage trial in patients with a type of fatty liver disease by reducing ...